Cannabinoids and Nutraceuticals: Synergistic Approaches in ModernTherapeutics

Abstract: This paper explores the synergistic potential of cannabinoids and nutraceuticals in modern therapeutic applications. Nutraceuticals, a term coined to highlight the fusion of nutrition and pharmaceuticals, include various supplements and functional foods that offer health benefits beyond basic nutrition. Cannabinoids, derived from Cannabis sativa, interact with the body's endocannabinoid system (ECS) to regulate key physiological processes, such as inflammation and pain management. The therapeutic benefits of cannabinoids, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), have shown promise in managing conditions like chronic pain, epilepsy, and neurodegenerative disorders. This review emphasizes the role of nutraceuticals in enhancing cannabinoid efficacy by improving bioavailability and providing complementary antioxidant and anti-inflammatory properties. The combined use of nutraceuticals like omega-3 fatty acids, curcumin, and piperine with cannabinoids has been shown to enhance therapeutic outcomes, including neuroprotection, pain relief, and inflammation control. Moreover, the study addresses the challenges of bioavailability and the regulatory landscape of these compounds, highlighting the need for further research to optimize their clinical applications. Integrating cannabinoids and nutraceuticals into personalized medicine and modern pharmacotherapy offers a pathway to more effective, safer treatments, positioning these compounds as valuable tools in managing chronic and complex conditions.